Multimodal MRI in Multiple Sclerosis (MS): Reliability and Follow Up

Groupe Hospitalier Pitie-Salpetriere

Status: Unknown

Conditions: Multiple Sclerosis

Study type: Observational

Funder types: Other

Identifiers

NCT00289159

RBM0110

Details and patient eligibility

About

To determine wether multimodal MRI (conventinal T1 and T2 sequences, diffusion, magnetization transfer, spectroscopy) is reproducible; to follow up a cohort of patients with early remmittent MS after treatment with interferon.

Sex: All

Ages: 18 to 50 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• MS patients according to Poser's criteria
• Remitting evolution (less than two years of evolution)
• Aged 18-50
• Immunomodulatory treatment indicated

Exclusion criteria

• Unable to perform MRI